You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Litigation Details for Huawei Technologies, Co, Ltd v. Samsung Electronics Co, Ltd. (N.D. Cal. 2016)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Huawei Technologies, Co, Ltd v. Samsung Electronics Co, Ltd.
The small molecule drug covered by the patent cited in this case is ⤷  Sign Up .

Details for Huawei Technologies, Co, Ltd v. Samsung Electronics Co, Ltd. (N.D. Cal. 2016)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2017-08-31 168 Order 166 patent”); 8,812,848; 8,644,239 (“the ’239 patent”); 8,885,587; 8,885,583; 8,639,246…27 ’246 patent”); 8,412,197 (“the ’197 patent”); 8,996,003; and 8,724,613 (“the ’613 patent”). …26 Huawei has asserted U.S. Patent Nos. 8,369,278 (“the ’278 patent”); 8,416,892; 8,483,166 (“the …Samsung has asserted U.S. Patent Nos. 8,228,827, 8,315,195 (“the ’195 patent”), RE44,105, …8,457,588 (“the ’588 patent”), 8,509,350, 9,113,419, 8,619,726 (“the ’726 patent”), 8,761,130 External link to document
2017-10-03 191 Writ Issued U.S. Patent Nos. 8,369,278; 8,416,892; 8,483,166; 8,812,848; 8,644,239; 8,885,587; 8,885,583; 8,639,246;…standard-essential patents (“SEPS”). In addition, Huawei alleged that Samsung infringes eleven of its patents: U.S.…alleged that Huawei infringes nine of its patents: U.S. Patent Nos. 8,228,827; 8,315,195; RE44,105; 8,…that they infringe the patents asserted against them and contend that the patents asserted against them…art exists that anticipates the patented claims or renders the patented claims obvious. Huawei has alleged External link to document
2018-06-26 318 Huawei's Updated Election of Asserted Claims and Accused Products (REDACTE • U.S. Patent 8,416,892, claims 1, 10 9 • U.S. Patent 8,644,239, claims 7, 18 10…currently asserted 5 patents to 4, narrows its currently asserted patent claims to no more than 10…10 • U.S. Patent 8,885,587, claims 3, 9 11 • U.S. Patent 8,724,613, claims 1, 5 12…purposes of assessing 17 infringement of Huawei’s patents. Therefore, provided that the parties enter or …2016 25 March 2019 3:16-cv-02787 830 Patent Both District Court, N.D. California External link to document
2018-06-29 323 Notice (Other) . R1-072330 + US Patent App. Pub. No. 2007/0230600 21 U.S. Patent 8,644,239 22 … U.S. Patent 8,885,587 6 14. U.S. Patent No. 8,472,368 7 15. U.S. Patent No. 8,472,368…-070189 + US Patent App. Pub. No. 2007/0230600 16 4. R1-071471 + US Patent App. Pub. No.…6. R1-072330 19 7. US Patent No. 8,477,698 + US Patent App. Pub. No. 2007/0230600 20 …094545 + U.S. Patent No. 8,472,368 11 19. TS 36.213 v8.5.0 + R1-094545 + U.S. Patent No. 9,036,564 External link to document
2018-07-03 330 Motion to Strike Huawei patents 8,724,613 (“’613 patent”), 8,885,587 (“’587 patent”), 8,644,239 (“’239 patent”), 6 …and8,416,892 (“’892 patent”), and Samsung patents RE44,105 (“’105 patent”), 8,761,130 (“’130 7 patent”), 9,288,825…the ’105 patent. 7 D. Samsung’s ’130 Patent 8 Samsung’s ’130 patent relates to…9,288,825 (“’825 patent”), and 8,619,726 (“’726 patent”). 8 I. BACKGROUND 9 This Court… 4 contribution to the patent office during examination of the ’613 patent, which makes the contribution External link to document
2018-07-03 331 Exhibit 17 8,483,166; 8,644,239; 8,885,587; 8,412,197; and 8,724,613) (collectively, “Huawei Patents”), and the…innovation, as the ‘166 Patent. 3. US8644239 132. US 8,644,239 was issued to Bingyu…“Unwired Planet Patents”), the six Huawei patents asserted in this case (U.S. Patent Nos. 8,416,892; …Planet Patents are not technically comparable to the Huawei Patents. The Unwired Planet Patents do not…COMPARISON BETWEEN UNWIRED PLANET PATENTS AND ASSERTED HUAWEI AND SAMSUNG PATENTS .......................... External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.